Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael D Prados
Affiliation
University of California san francisco
ORCID
Career Start Year
1987
Papers
376
H Index
98
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37978951
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
J Clin Oncol
2024
37978951
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
J Clin Oncol
2024
36335802
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Neoplasia
2023
36335802
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.
Neoplasia
2023
37935104
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
J Clin Oncol
2023
37627881
Current Strategies for Management of Medulloblastoma.
Diagnostics (Basel)
2023
37091147
Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.
Front Oncol
2023
37149933
Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.
Neoplasia
2023
36581779
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
J Neurooncol
2023
37318058
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.
Neuro Oncol
2023
36630480
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.
Sci Transl Med
2023
37443252
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.
Nat Nanotechnol
2023
37051331
Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study.
Neurooncol Adv
2023
37492101
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell Genom
2023
37627881
Current Strategies for Management of Medulloblastoma.
Diagnostics (Basel)
2023
37935104
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.
J Clin Oncol
2023
37492101
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell Genom
2023
37318058
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma.
Neuro Oncol
2023
37149933
Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology.
Neoplasia
2023
37051331
Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study.
Neurooncol Adv
2023
37443252
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles.
Nat Nanotechnol
2023
37091147
Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks.
Front Oncol
2023
36581779
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
J Neurooncol
2023
36630480
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.
Sci Transl Med
2023
35852795
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Clin Cancer Res
2022
35703183
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
J Clin Invest
2022
35852795
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
Clin Cancer Res
2022
35703183
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
J Clin Invest
2022
33272950
Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.
AJNR Am J Neuroradiol
2021
34125374
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
J Neurooncol
2021
33957633
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology
2021
33272950
Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.
AJNR Am J Neuroradiol
2021
34125374
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
J Neurooncol
2021
33957633
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology
2021
32257279
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.
Neurooncol Pract
2020
32027343
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
JAMA Oncol
2020
32257279
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.
Neurooncol Pract
2020
32476174
Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas.
J Clin Pharmacol
2020
32817593
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
J Clin Invest
2020
32523649
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).
Oncotarget
2020
32743548
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.
Neurooncol Adv
2020
33235994
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
Neurooncol Adv
2020
32502458
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
2020
32027343
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
JAMA Oncol
2020
33235994
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
Neurooncol Adv
2020
32743548
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.
Neurooncol Adv
2020
32817593
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
J Clin Invest
2020
32476174
Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas.
J Clin Pharmacol
2020
32502458
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol
2020
32523649
Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).
Oncotarget
2020
1 - 50 of 752
Column Actions
Search
Recommended Authors
Priya Kumthekar
Northwestern University, Feinberg School of Medicine
Career Start Year
2013
Number of shared co-authors
23
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year
2009
Number of shared co-authors
13
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year
2008
Number of shared co-authors
41
Josef Pichler
Kepler University Hospital
Career Start Year
2006
Number of shared co-authors
10
Adam M Sonabend
Northwestern University
Career Start Year
2005
Number of shared co-authors
15
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
15
Matthias Preusser
Medical University of Vienna
Career Start Year
2003
Number of shared co-authors
42
Thomas J Kaley
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
23
Gelareh Zadeh
University of Toronto
Career Start Year
2003
Number of shared co-authors
78
Martin Glas
University Hospital Essen
Career Start Year
2002
Number of shared co-authors
7
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year
2001
Number of shared co-authors
1
Mariza Daras
University of California san francisco
Career Start Year
2001
Number of shared co-authors
26
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year
2000
Number of shared co-authors
10
W K Alfred Yung
The University of Texas MD Anderson Cancer Center
Career Start Year
2000
Number of shared co-authors
11
Michelle Alonso-Basanta
Perelman School of Medicine, University of Pennsylvania
Career Start Year
2000
Number of shared co-authors
5
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
1998
Number of shared co-authors
22
John A Boockvar
Lenox Hill Hospital
Career Start Year
1997
Number of shared co-authors
3
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year
1996
Number of shared co-authors
26
Clark C Chen
University of Minnesota
Career Start Year
1994
Number of shared co-authors
24
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
1994
Number of shared co-authors
10
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year
1991
Number of shared co-authors
15
G??nther Stockhammer
Medical University of Innsbruck
Career Start Year
1990
Number of shared co-authors
1
Roger Stupp
Northwestern University
Career Start Year
1990
Number of shared co-authors
30
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year
1988
Number of shared co-authors
9
Camilo E Fadul
University of Virginia Health System
Career Start Year
1987
Number of shared co-authors
7
Michael Weller
University Hospital and University of Zurich
Career Start Year
1987
Number of shared co-authors
66
Christine Marosi
Medical University of Vienna
Career Start Year
1987
Number of shared co-authors
2
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year
1984
Number of shared co-authors
12
Jonathan L Finlay
Nationwide Children's Hospital and The Ohio State University
Career Start Year
1980
Number of shared co-authors
46
John P Kirkpatrick
Duke University Medical Center
Career Start Year
1978
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Mitchel S Berger
University of California san francisco
Co-authored papers
79
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers
60
Timothy F Cloughesy
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
58
Patrick Y Wen
Co-authored papers
56
Minesh P Mehta
Co-authored papers
41
Nicholas Butowski
University of California san francisco
Co-authored papers
40
Michael W McDermott
University of California san francisco
Co-authored papers
39
John G Kuhn
Co-authored papers
38
Kenneth Aldape
National Cancer Institute
Co-authored papers
35
Penny K Sneed
University of California San Francisco
Co-authored papers
33
Annette M Molinaro
Co-authored papers
28
Daphne A Haas-Kogan
Co-authored papers
26
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers
23
Charles D James
Co-authored papers
23
David Schiff
University of Virginia School of Medicine
Co-authored papers
23
Howard A Fine
Meyer Cancer Center
Co-authored papers
21
Nalin Gupta
Co-authored papers
19
Anuradha Banerjee
Co-authored papers
19
Joanna J Phillips
University of California san francisco
Co-authored papers
17
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers
17
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers
17
Roger J Packer
Brain Tumor Institute, Children's National Hospital
Co-authored papers
17
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers
15
Stewart Goldman
Co-authored papers
14
John F de Groot
Co-authored papers
13
Theodore Nicolaides
Co-authored papers
12
Mei-Yin C Polley
Co-authored papers
10
Keith L Ligon
Co-authored papers
10
Rintaro Hashizume
Co-authored papers
10
Henry S Friedman
Co-authored papers
10
1 - 30